DK1787126T3 - Fremgangsmåde til karakterisering af en polyklonal cellelinie - Google Patents

Fremgangsmåde til karakterisering af en polyklonal cellelinie

Info

Publication number
DK1787126T3
DK1787126T3 DK05760790T DK05760790T DK1787126T3 DK 1787126 T3 DK1787126 T3 DK 1787126T3 DK 05760790 T DK05760790 T DK 05760790T DK 05760790 T DK05760790 T DK 05760790T DK 1787126 T3 DK1787126 T3 DK 1787126T3
Authority
DK
Denmark
Prior art keywords
cell line
polyclonal
platform
polyclonal cell
characterizing
Prior art date
Application number
DK05760790T
Other languages
Danish (da)
English (en)
Inventor
Torben Frandsen
Lone Kjaer Rasmussen
Soeren Kofoed Rasmussen
Peter Sejer Andersen
Original Assignee
Symphogen As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symphogen As filed Critical Symphogen As
Application granted granted Critical
Publication of DK1787126T3 publication Critical patent/DK1787126T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/96Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation using ion-exchange
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Document Processing Apparatus (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK05760790T 2004-07-20 2005-07-20 Fremgangsmåde til karakterisering af en polyklonal cellelinie DK1787126T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200401133 2004-07-20
DKPA200401991 2004-12-22
PCT/DK2005/000504 WO2006007853A2 (en) 2004-07-20 2005-07-20 A procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line

Publications (1)

Publication Number Publication Date
DK1787126T3 true DK1787126T3 (da) 2009-12-21

Family

ID=35427551

Family Applications (2)

Application Number Title Priority Date Filing Date
DK05760790T DK1787126T3 (da) 2004-07-20 2005-07-20 Fremgangsmåde til karakterisering af en polyklonal cellelinie
DK09151073.5T DK2053408T3 (da) 2004-07-20 2005-07-20 Fremgangsmåde til strukturel karakterisering af et rekombinant polyklonalt protein eller en polyklonal cellelinje

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK09151073.5T DK2053408T3 (da) 2004-07-20 2005-07-20 Fremgangsmåde til strukturel karakterisering af et rekombinant polyklonalt protein eller en polyklonal cellelinje

Country Status (19)

Country Link
US (2) US8288109B2 (ru)
EP (2) EP2053408B1 (ru)
JP (1) JP4870667B2 (ru)
KR (1) KR101319848B1 (ru)
AT (2) ATE548657T1 (ru)
AU (1) AU2005263334C1 (ru)
BR (1) BRPI0513714A (ru)
CA (1) CA2574146C (ru)
DE (1) DE602005016818D1 (ru)
DK (2) DK1787126T3 (ru)
ES (2) ES2332524T3 (ru)
HK (2) HK1101043A1 (ru)
IL (2) IL180169A (ru)
MX (1) MX2007000551A (ru)
NO (1) NO20070931L (ru)
NZ (1) NZ552264A (ru)
PL (2) PL2053408T3 (ru)
RU (1) RU2426795C2 (ru)
WO (1) WO2006007853A2 (ru)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1762617A1 (en) 2003-01-07 2007-03-14 Symphogen A/S Method for manufacturing recombinant polyclonal proteins
TWI333977B (en) 2003-09-18 2010-12-01 Symphogen As Method for linking sequences of interest
NZ552264A (en) 2004-07-20 2010-03-26 Symphogen As A procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line
CA2574062A1 (en) 2004-07-20 2006-01-26 Symphogen A/S Anti-rhesus d recombinant polyclonal antibody and methods of manufacture
US7850965B2 (en) 2005-12-05 2010-12-14 Symphogen A/S Anti-orthopoxvirus recombinant polyclonal antibody
US8338376B2 (en) 2006-10-20 2012-12-25 Biogen Idec Ma Inc. Compositions comprising variant LT-B-R-IG fusion proteins
CA2676049C (en) * 2007-03-01 2018-04-10 Symphogen A/S Recombinant anti-epidermal growth factor receptor antibody compositions
SI2121920T1 (sl) * 2007-03-01 2011-12-30 Symphogen As Postopek za kloniranje sorodnih protiteles
CA2678628A1 (en) * 2007-03-06 2008-09-12 Symphogen A/S Recombinant antibodies for treatment of respiratory syncytial virus infections
EP2139509A2 (en) * 2007-03-15 2010-01-06 Biogen Idec MA, Inc. Treatment of autoimmune disorders
CN101688204B (zh) 2007-05-25 2013-07-03 西福根有限公司 用于制造重组多克隆蛋白质的方法
JP2008289483A (ja) * 2007-05-25 2008-12-04 Symphogen As 真核生物系において発現可能な形質転換体のスクリーニング
RU2010113510A (ru) * 2007-09-07 2011-10-20 Симфоген А/С (Dk) Способы рекомбинантной продукции антител против респираторно-цинцитиального вируса (rsv)
NZ584684A (en) 2007-11-22 2012-10-26 Symphogen As A method for characterization of a recombinant polyclonal protein
SG189793A1 (en) * 2008-04-23 2013-05-31 Symphogen As Methods for manufacturing a polyclonal protein
AU2009287163B2 (en) 2008-08-29 2014-11-13 Les Laboratoires Servier Recombinant anti-Epidermal Growth Factor Receptor antibody compositions
KR20110058861A (ko) * 2008-08-29 2011-06-01 심포젠 에이/에스 조류 유래 항체의 클로닝 방법
WO2011028961A2 (en) 2009-09-04 2011-03-10 Xoma Technology Ltd. Anti-botulism antibody coformulations
CA2776508A1 (en) * 2009-10-09 2011-04-14 Symphogen A/S Multiplex quantitation of individual recombinant proteins in a mixture by signature peptides and mass spectrometry
WO2011130377A2 (en) * 2010-04-15 2011-10-20 Abbott Laboratories Amyloid-beta binding proteins
ES2616961T3 (es) 2010-11-01 2017-06-14 Symphogen A/S Composición de anticuerpos pan-HER
US9790269B2 (en) 2013-02-08 2017-10-17 Misfolding Diagnostics, Inc. Transthyretin antibodies and uses thereof
UY35517A (es) 2013-04-04 2014-10-31 Mabxience S A Un procedimiento para aumentar la formación de ácido piroglutamico de una proteína
WO2015093925A1 (es) * 2013-12-19 2015-06-25 CASTRO ALDRETE, Jorge Isaac Método de producción de anticuerpos específicos
TW201623331A (zh) * 2014-03-12 2016-07-01 普羅帝納生物科學公司 抗黑色素瘤細胞黏著分子(mcam)抗體類及使用彼等之相關方法
EP3497444A4 (en) * 2016-08-12 2020-11-11 Abreos Biosciences, Inc. DETECTION AND QUANTIFICATION OF NATALIZUMAB
CA3104390A1 (en) * 2018-06-22 2019-12-26 Genmab A/S Method for producing a controlled mixture of two or more different antibodies
CN112816595A (zh) * 2021-01-06 2021-05-18 海默斯(重庆)医学生物技术有限公司 一种重组角蛋白液体制剂及其纯度检测方法

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985002413A1 (en) 1983-11-28 1985-06-06 The Board Of Trustees Of The Leland Stanford Jr. U HUMAN MONOCLONAL ANTIBODY AGAINST Rh(D) ANTIGEN AND ITS USES
IL78775A (en) * 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines
CA1293460C (en) 1985-10-07 1991-12-24 Brian Lee Sauer Site-specific recombination of dna in yeast
US5126130A (en) 1986-11-24 1992-06-30 The Childrens Hospital Incorporated Monoclonal antibodies reactive with specific antigenic sites on human cytomegalovirus glycoprotein a
GB8722019D0 (en) 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
GB8722020D0 (en) 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
GB8722018D0 (en) 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
DE68913658T3 (de) 1988-11-11 2005-07-21 Stratagene, La Jolla Klonierung von Immunglobulin Sequenzen aus den variablen Domänen
GB8906129D0 (en) 1989-03-17 1989-05-04 Central Blood Lab Authority Pharmaceutical preparations
GB8919761D0 (en) 1989-09-01 1989-10-18 Central Blood Lab Authority Chemical compounds
WO1992015694A1 (en) 1991-03-08 1992-09-17 The Salk Institute For Biological Studies Flp-mediated gene modification in mammalian cells, and compositions and cells useful therefor
US5837268A (en) 1991-10-16 1998-11-17 University Of Saskatchewan GnRH-leukotoxin chimeras
US5252216A (en) * 1992-03-24 1993-10-12 Smithkline Beecham Corporation Protein purification
CA2116246A1 (en) 1992-06-26 1994-01-06 Roland Beliard Human monoclonal anti-rhesus (d) antibodies and cell lines producing same
US5538848A (en) 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
AU1736495A (en) * 1994-01-31 1995-08-15 Trustees Of Boston University Polyclonal antibody libraries
FR2724182B1 (fr) 1994-09-02 1996-12-13 Pasteur Institut Obtention d'un anticorps monoclonal recombinant a partir d'un anticorps monoclonal humain anti-rhesus d, sa production en cellules d'insecte, et ses utilisations
US6111166A (en) 1994-09-19 2000-08-29 Medarex, Incorporated Transgenic mice expressing human Fcα and β receptors
PL186019B1 (pl) 1996-06-24 2003-09-30 Zlb Bioplasma Ag Polipeptydy zdolne do tworzenia struktur wiążących antygen o swoistości względem antygenów Rh D, sekwencje DNA kodujące te polipeptydy oraz sposób ich wytwarzania i stosowania
US6255455B1 (en) 1996-10-11 2001-07-03 The Trustees Of The University Of Pennsylvania Rh(D)-binding proteins and magnetically activated cell sorting method for production thereof
US5876925A (en) 1996-10-11 1999-03-02 The Trustees Of The University Of Pennsylvania Magnetically activated cell sorting for production of proteins
JP4128227B2 (ja) 1997-03-14 2008-07-30 バイオジェン・アイデック・インコーポレイテッド 哺乳類細胞内の特定部位に相同組換えによって遺伝子を組み込む方法とそれを実施するためのベクター
JPH11174038A (ja) * 1997-12-10 1999-07-02 Tosoh Corp 蛋白質の分離精製法
WO2000011155A1 (en) 1998-08-19 2000-03-02 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for genomic modification
US20020155114A1 (en) * 1998-08-31 2002-10-24 James D. Marks Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
WO2001006233A1 (en) * 1999-07-16 2001-01-25 Human Genome Sciences, Inc. Real-time, in situ biomanufacturing process monitoring and control in response to ir spectroscopy
DK1234022T3 (da) 1999-07-23 2010-07-19 Univ California DNA-rekombination i eukaryote celler med bakteriofag PHIC31-rekombinationssystemet
EP1106625A1 (en) 1999-11-17 2001-06-13 ZLB Bioplasma AG Rhesus D specific peptide sequences
CA2401663C (en) 2000-02-08 2008-11-25 The Regents Of The University Of Michigan Protein mapping
MXPA02007664A (es) 2000-02-08 2004-08-23 Univ Michigan Separacion y representacion de proteinas.
EP1256001A2 (en) 2000-02-08 2002-11-13 The Regents Of The University Of Michigan Mapping of differential display of proteins
AU6206701A (en) 2000-05-26 2001-12-03 Symphogen As Recombinant or purified polyclonal antibodies for treating allergy
US6610472B1 (en) 2000-10-31 2003-08-26 Genetastix Corporation Assembly and screening of highly complex and fully human antibody repertoire in yeast
AU2002239369A1 (en) 2000-11-28 2002-06-11 Applied Molecular Evolution, Inc. Eukaryotic expression libraries based on double lox recombination and methods of use
DE60142650D1 (de) 2000-12-26 2010-09-02 Inst Systems Biology Seattle Schnelle und quantitative Proteomanalyse und entsprechende Verfahren
US7541003B2 (en) * 2001-07-17 2009-06-02 Bio-Rad Laboratories, Inc. Latex based adsorbent chip
JP4767496B2 (ja) * 2001-12-08 2011-09-07 マイクロマス ユーケー リミテッド マススペクトル測定方法
AU2003237282A1 (en) 2002-05-31 2003-12-19 The Regents Of The University Of Michigan Automated protein analysis system comprising capillary electrophoresis-tandem mass spectrometry
ES2442615T5 (es) * 2002-07-18 2023-03-16 Merus Nv Producción recombinante de mezclas de anticuerpos
JP2004101477A (ja) * 2002-09-12 2004-04-02 Yoshio Yamauchi 2次元高速液体クロマトグラフ装置及びそれを用いた蛋白質分析装置
US20040137526A1 (en) 2002-10-15 2004-07-15 The Regents Of The University Of Michigan Multidimensional protein separation system
US20060275766A1 (en) * 2003-01-07 2006-12-07 Haurum John S Method for manufacturing recombinant polyclonal proteins
EP1762617A1 (en) * 2003-01-07 2007-03-14 Symphogen A/S Method for manufacturing recombinant polyclonal proteins
TWI333977B (en) 2003-09-18 2010-12-01 Symphogen As Method for linking sequences of interest
NZ552264A (en) 2004-07-20 2010-03-26 Symphogen As A procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line
CA2574062A1 (en) 2004-07-20 2006-01-26 Symphogen A/S Anti-rhesus d recombinant polyclonal antibody and methods of manufacture
US7850965B2 (en) 2005-12-05 2010-12-14 Symphogen A/S Anti-orthopoxvirus recombinant polyclonal antibody
MX2008011280A (es) 2006-03-06 2008-09-12 Symphogen As Anticuerpor policlonal recombinante para el tratamiento de infecciones por el virus sincitial respiratorio.
NZ584684A (en) 2007-11-22 2012-10-26 Symphogen As A method for characterization of a recombinant polyclonal protein

Also Published As

Publication number Publication date
IL203017A (en) 2013-08-29
RU2007106050A (ru) 2008-08-27
ES2332524T3 (es) 2010-02-08
IL180169A (en) 2011-04-28
JP4870667B2 (ja) 2012-02-08
PL2053408T3 (pl) 2012-08-31
AU2005263334A1 (en) 2006-01-26
DK2053408T3 (da) 2012-06-04
EP1787126B1 (en) 2009-09-23
US20130203063A1 (en) 2013-08-08
WO2006007853A2 (en) 2006-01-26
US8288109B2 (en) 2012-10-16
ES2381531T3 (es) 2012-05-29
BRPI0513714A (pt) 2008-05-13
EP2053408A2 (en) 2009-04-29
EP2053408A3 (en) 2009-07-29
US20080131882A1 (en) 2008-06-05
ATE443870T1 (de) 2009-10-15
RU2426795C2 (ru) 2011-08-20
HK1101043A1 (en) 2007-10-05
CA2574146A1 (en) 2006-01-26
KR20070032078A (ko) 2007-03-20
HK1133076A1 (en) 2010-03-12
PL1787126T3 (pl) 2010-03-31
DE602005016818D1 (de) 2009-11-05
EP2053408B1 (en) 2012-03-07
AU2005263334C1 (en) 2011-01-20
AU2005263334B2 (en) 2010-08-05
KR101319848B1 (ko) 2013-10-18
CA2574146C (en) 2015-06-30
US9029091B2 (en) 2015-05-12
JP2008506960A (ja) 2008-03-06
EP1787126A2 (en) 2007-05-23
WO2006007853A3 (en) 2006-05-18
ATE548657T1 (de) 2012-03-15
NO20070931L (no) 2007-04-17
MX2007000551A (es) 2007-03-30
NZ552264A (en) 2010-03-26
IL180169A0 (en) 2007-06-03

Similar Documents

Publication Publication Date Title
DK1787126T3 (da) Fremgangsmåde til karakterisering af en polyklonal cellelinie
BRPI0507433C1 (pt) anticorpo monoclonal recombinante ou sua parte de ligação ao antígeno, composição, ácido nucleico isolado, vetor de expressão, e, kit
CY1117702T1 (el) Πρωτεϊνες δεσμευομενες με αντιγονο ικανες να δεσμευονται με θυμικη στρωματικη λεμφοποιητινη
ATE554390T1 (de) Verfahren zur gewinnung von antikörpern
MX2010005377A (es) Metodo para caracterizacion de proteina policlonal recombinante.
WO2005066867A3 (en) Modulators of cell-surface receptors of the ig-class
EA200700751A1 (ru) Способы и композиции для улучшения продуцирования рекомбинантного белка
IS8016A (is) Prótín sem bindast viðtaka NOGO
WO2009010539A3 (en) Receptor for interleukin-6 (il-6) from macaca fascicularis
DE602005013947D1 (de) Antikörper gegen hundepankreaslipase
BRPI0820885B8 (pt) "anticorpo ou fraguimento do mesmo, célula de hibridoma, polinucleotídeo, polipeptídeo compreendendoum domínio de cadeia pesada ou leve de anticorpo, método para detecção de gravidez em um animal bovino, kit e método de purificação de um antígeno principal associado à gravidez (pag)".
DK2185937T3 (da) Fremgangsmåde til at bestemme sepsis hos mennesker
WO2005106494A3 (en) Monoclonal antibodies, hybridomas, improved method for determining the protein ptx3 and kit for said determination
WO2009132132A3 (en) Prediction of an individual's risk of developing rheumatoid arthritis
Furlong et al. An exploratory universal LC–MS/MS assay for bioanalysis of hinge region-stabilized human IgG4 mAbs in clinical studies
WO2006033974A3 (en) Detection of protein aggregates by homologous elisa
WO2005019831A3 (en) Methods for reducing complexity of a sample using small epitope antibodies
ATE538217T1 (de) Erkennung von ektopischen schwangerschaften
DE602005022757D1 (de) Verwendung von endosialinbindenden proteinen zum isolieren endosialinpositiver zellen
ATE532796T1 (de) Immunassays zur spezifischen bestimmung von scca- isoformen
Mehand et al. Estimation of analyte concentration by surface plasmon resonance-based biosensing using parameter identification techniques
Altinier et al. An IgE multiple myeloma: contradictory findings in clinical laboratory testing
WO2004084841A3 (en) Novel anti-feline albumin antibodies and methods of detecting early renal disease
ATE423133T1 (de) Verfahren und materialien zur behandlung von entzündungen unter verwendung eines polypeptides das einen eigenen-c5 aminosaüresegment und einen nicht-eigenen aminosaüresegment enthält
WO2005058362A3 (en) Method for opening tight junctions comprising the use of jam-1, claudin-4 and occludin protein antagonists as well as sirna molecules